We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Rosetta Genomics (ROSG) - microRNA
An SI Board Since July 2007
Posts SubjectMarks Bans Symbol
58 8 0 ROSG
Emcee:  Microcap Analyst Type:  Unmoderated
Rosetta Genomics seeks to develop and commercialize diagnostic and therapeutic products based on a group of genes known as micro-ribonucleic acid (microRNAs).

MicroRNAs are naturally expressed, or produced, using instructions encoded in deoxyribonucleic acid (DNA). The Company has developed a discovery process that integrates computer-based algorithms and customized biological techniques in order to discover and biologically validate microRNAs.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
58A serious delay for the blood-based colorectal cancer screen test and CEO steppiidos-9/11/2009
57Nice.nigel bates-4/13/2009
56SAN DIEGO, PHILADELPHIA and REHOVOT, Israel, April 13, 2009 /PRNewswire via COMTLJM-4/13/2009
55Rosetta should seek volunteers in the USA-----think I could find a few who avoidMJ-3/27/2009
54<b>Rosetta Genomics Could Debut Colon Cancer Screen in US This Year, Shiftidos-3/27/2009
53<b>Key microRNA Diagnostic/Screen Pipelines as of March 19, 2009</b>idos-3/20/2009
52Tissue of origin - competition: <b>Genetic Tests May Reveal Source of Mysidos-3/11/2009
51Study Published by Rosetta Genomics and Collaborators in the Journal of ClinicalLJM-3/9/2009
50Cannot open their study link (at the bottom of the PR), but results sound encouridos-2/12/2009
49Yes and that was after sqnm explained that the exas prenatal technology would berkrw-1/29/2009
48And SQNM had to give up its offer to acquire EXAS after the latter got a deal wiidos-1/29/2009
47Seems like "very sticky" secretions might be hard to fix in colonoscopSteve Lokness-1/23/2009
46Agree on that. Seen the results with GIVN's pill (although there are additioidos-1/20/2009
45So far, ROSG' tests are regulated by CLIA and there is no indication that thidos-1/20/2009
44FDA wants prospectively defined retrospective data. Identify the genes you want rkrw-1/18/2009
43Tuck; <i> I mean a controlled and blinded trial.</i> Welll, the prSteve Lokness-1/18/2009
42Steve, there are so many stories of invasive procedures that fail or damage the MJ-1/18/2009
41By trials in humans, I mean a controlled and blinded trial. See also this: fdatuck-1/18/2009
40It's not that easy selling a diagnostic test and rosg has no sales force andrkrw-1/18/2009
39<i>The trouble with the test is the data hasn't been very good.</i&Steve Lokness-1/18/2009
38MJ; <i>I will never have another again in my life</i> Me neither uSteve Lokness-1/18/2009
37Tuck; <i>They'd still have to do trials in humans,</i> Why? Steve Lokness-1/18/2009
36Any time new techniques enter there is massive opposition i.e. when the whole boMJ-1/17/2009
35Wow, I started something there! I guess I was being a little harsh. The PR hadtuck-1/17/2009
34The trouble with the test is the data hasn't been very good. Someone could rkrw-1/17/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):